Article (Scientific journals)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Reiner, Zeljko; Catapano, Alberico L; De Backer, Guy et al.
2011In European Heart Journal, 32 (14), p. 1769-818
Peer Reviewed verified by ORBi
 

Files


Full Text
Reiner_Eur Heart J_2011_32_1769.pdf
Publisher postprint (6.51 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adult; Cardiovascular Diseases/prevention & control; Child; Diet; Dietary Fats/administration & dosage; Dietary Supplements; Dyslipidemias/diet therapy/drug therapy/prevention & control; Early Diagnosis; Energy Intake/physiology; Exercise; Female; Humans; Hypolipidemic Agents/therapeutic use; Kidney Failure, Chronic/complications; Life Style; Lipid Metabolism; Male; Patient Compliance; Primary Prevention/methods; Risk Assessment; Risk Factors; Secondary Prevention/methods; Specimen Handling/methods; Transplantation/adverse effects; Weight Loss
Abstract :
[en] Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and is also increasingly common in developing countries.1 In the European Union, the economic cost of CVD represents annually E192 billion1 in direct and indirect healthcare costs. The main clinical entities are coronary artery disease (CAD), ischaemic stroke, and peripheral arterial disease (PAD). The causes of these CVDs are multifactorial. Some of these factors relate to lifestyles, such as tobacco smoking, lack of physical activity, and dietary habits, and are thus modifiable. Other risk factors are also modifiable, such as elevated blood pressure, type 2 diabetes, and dyslipidaemias, or non-modifiable, such as age and male gender. These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. Prevention and treatment of dyslipidaemias should always be considered within the broader framework of CVD prevention, which is addressed in guidelines of the Joint European Societies' Task forces on CVD prevention in clinical practice.2 - 5 The latest version of these guidelines was published in 20075; an update will become available in 2012. These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Reiner, Zeljko
Catapano, Alberico L
De Backer, Guy
Graham, Ian
Taskinen, Marja-Riitta
Wiklund, Olov
Agewall, Stefan
Alegria, Eduardo
Chapman, M John
Durrington, Paul
Erdine, Serap
Halcox, Julian
Kjekshus, John
Filardi, Pasquale Perrone
Riccardi, Gabriele
Storey, Robert F
Wood, David
Bax, Jeroen
Vahanian, Alec
Auricchio, Angelo
Baumgartner, Helmut
Ceconi, Claudio
Dean, Veronica
Deaton, Christi
Fagard, Robert
Filippatos, Gerasimos
Funck-Brentano, Christian
Hasdai, David
Hobbs, Richard
Hoes, Arno
Kearney, Peter
Knuuti, Juhani
Kolh, Philippe  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
McDonagh, Theresa
Moulin, Cyril
Poldermans, Don
Popescu, Bogdan Alexandru
Sechtem, Udo
Sirnes, Per Anton
Tendera, Michal
Torbicki, Adam
Vardas, Panos
Widimsky, Petr
Windecker, Stephan
Berkenboom, Guy
De Graaf, Jacqueline
Descamps, Olivier
Gotcheva, Nina
Griffith, Kathryn
Guida, Guido Francesco
Gulec, Sadi
Henkin, Yaakov
Huber, Kurt
Kesaniemi, Y Antero
Lekakis, John
Manolis, Athanasios J
Marques-Vidal, Pedro
Masana, Luis
McMurray, John
Mendes, Miguel
Pagava, Zurab
Pedersen, Terje
Prescott, Eva
Rato, Quiteria
Rosano, Giuseppe
Sans, Susana
Stalenhoef, Anton
Tokgozoglu, Lale
Viigimaa, Margus
Wittekoek, M. E.
Zamorano, Jose Luis
More authors (61 more) Less
Language :
English
Title :
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Publication date :
2011
Journal title :
European Heart Journal
ISSN :
0195-668X
eISSN :
1522-9645
Publisher :
Oxford University Press, Oxford, United Kingdom
Volume :
32
Issue :
14
Pages :
1769-818
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 January 2012

Statistics


Number of views
2370 (4 by ULiège)
Number of downloads
2113 (2 by ULiège)

Scopus citations®
 
2618
Scopus citations®
without self-citations
2435
OpenCitations
 
1963

Bibliography


Similar publications



Contact ORBi